APO Research
Talk to an analyst

APO RESEARCH · REPORT

Targeted Therapy Drugs for Melanoma

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Targeted Therapy Drugs for Melanoma Industry Growth and Trends Forecast to 2032

28 December 202572 pages

Choose your research edition.

Industry ResearchTargeted Therapy Drugs for Melanoma Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Targeted Therapy Drugs for Melanoma Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Targeted Therapy Drugs for Melanoma Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Targeted Therapy Drugs for Melanoma Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Targeted Therapy Drugs for Melanoma Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Targeted Therapy Drugs for Melanoma market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Targeted Therapy Drugs for Melanoma is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Targeted Therapy Drugs for Melanoma is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Targeted Therapy Drugs for Melanoma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Targeted Therapy Drugs for Melanoma include Novartis, Pfizer, KeChow Pharmaceuticals and Roche, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Targeted Therapy Drugs for Melanoma market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Targeted Therapy Drugs for Melanoma market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Targeted Therapy Drugs for Melanoma market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Targeted Therapy Drugs for Melanoma.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Targeted Therapy Drugs for Melanoma market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Targeted Therapy Drugs for Melanoma Market by Company

Novartis

Pfizer

KeChow Pharmaceuticals

Roche

Targeted Therapy Drugs for Melanoma Segment by Type

MEK Inhibitors

BRAF Inhibitors

Other

Targeted Therapy Drugs for Melanoma Segment by Application

Hospital and Clinic

Pharmacy

Other

Targeted Therapy Drugs for Melanoma Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Targeted Therapy Drugs for Melanoma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Targeted Therapy Drugs for Melanoma and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Targeted Therapy Drugs for Melanoma.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Targeted Therapy Drugs for Melanoma manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Targeted Therapy Drugs for Melanoma in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of MEK Inhibitors Table 2. Major Company of BRAF Inhibitors Table 3. Major Company of Other Table 4. Global Targeted Therapy Drugs for Melanoma Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Targeted Therapy Drugs for Melanoma Sales by Type (2021-2026) & (K Units) Table 6. Global Targeted Therapy Drugs for Melanoma Sales Market Share in Volume by Type (2021-2026) Table 7. Global Targeted Therapy Drugs for Melanoma Sales by Type (2021-2026) & (US$ Million) Table 8. Global Targeted Therapy Drugs for Melanoma Sales Market Share in Value by Type (2021-2026) Table 9. Global Targeted Therapy Drugs for Melanoma Price by Type (2021-2026) & (US$/Unit) Table 10. Global Targeted Therapy Drugs for Melanoma Sales by Type (2027-2032) & (K Units) Table 11. Global Targeted Therapy Drugs for Melanoma Sales Market Share in Volume by Type (2027-2032) Table 12. Global Targeted Therapy Drugs for Melanoma Sales by Type (2027-2032) & (US$ Million) Table 13. Global Targeted Therapy Drugs for Melanoma Sales Market Share in Value by Type (2027-2032) Table 14. Global Targeted Therapy Drugs for Melanoma Price by Type (2027-2032) & (US$/Unit) Table 15. North America Targeted Therapy Drugs for Melanoma Sales by Type (2021-2026) & (K Units) Table 16. North America Targeted Therapy Drugs for Melanoma Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Targeted Therapy Drugs for Melanoma Sales by Type (2021-2026) & (K Units) Table 18. Europe Targeted Therapy Drugs for Melanoma Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Targeted Therapy Drugs for Melanoma Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Targeted Therapy Drugs for Melanoma Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Targeted Therapy Drugs for Melanoma Sales by Type (2021-2026) & (K Units) Table 22. Latin America Targeted Therapy Drugs for Melanoma Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Targeted Therapy Drugs for Melanoma Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Targeted Therapy Drugs for Melanoma Sales by Type (2021-2026) & (US$ Million) Table 25. Targeted Therapy Drugs for Melanoma Industry Trends Table 26. Targeted Therapy Drugs for Melanoma Industry Drivers Table 27. Targeted Therapy Drugs for Melanoma Industry Opportunities and Challenges Table 28. Targeted Therapy Drugs for Melanoma Industry Restraints Table 29. Global Targeted Therapy Drugs for Melanoma Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Targeted Therapy Drugs for Melanoma Revenue Market Share by Company (2021-2026) Table 31. Global Targeted Therapy Drugs for Melanoma Sales by Company (2021-2026) & (K Units) Table 32. Global Targeted Therapy Drugs for Melanoma Sales Share by Company (2021-2026) Table 33. Global Targeted Therapy Drugs for Melanoma Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Targeted Therapy Drugs for Melanoma Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Targeted Therapy Drugs for Melanoma Major Company Production Sites and Headquarters Table 36. Global Targeted Therapy Drugs for Melanoma Company, Product Type & Application Table 37. Global Targeted Therapy Drugs for Melanoma Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Targeted Therapy Drugs for Melanoma by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Targeted Therapy Drugs for Melanoma Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Targeted Therapy Drugs for Melanoma Sales by Region (2021-2026) & (K Units) Table 42. Global Targeted Therapy Drugs for Melanoma Sales Market Share in Volume by Region (2021-2026) Table 43. Global Targeted Therapy Drugs for Melanoma Sales by Region (2021-2026) & (US$ Million) Table 44. Global Targeted Therapy Drugs for Melanoma Sales Market Share in Value by Region (2021-2026) Table 45. Global Targeted Therapy Drugs for Melanoma Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Targeted Therapy Drugs for Melanoma Sales by Region (2027-2032) & (K Units) Table 47. Global Targeted Therapy Drugs for Melanoma Sales Market Share in Volume by Region (2027-2032) Table 48. Global Targeted Therapy Drugs for Melanoma Sales by Region (2027-2032) & (US$ Million) Table 49. Global Targeted Therapy Drugs for Melanoma Sales Market Share in Value by Region (2027-2032) Table 50. Global Targeted Therapy Drugs for Melanoma Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Targeted Therapy Drugs for Melanoma Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Targeted Therapy Drugs for Melanoma Sales by Application (2021-2026) & (K Units) Table 53. Global Targeted Therapy Drugs for Melanoma Sales Market Share in Volume by Application (2021-2026) Table 54. Global Targeted Therapy Drugs for Melanoma Sales by Application (2021-2026) & (US$ Million) Table 55. Global Targeted Therapy Drugs for Melanoma Sales Market Share in Value by Application (2021-2026) Table 56. Global Targeted Therapy Drugs for Melanoma Price by Application (2021-2026) & (US$/Unit) Table 57. Global Targeted Therapy Drugs for Melanoma Sales by Application (2027-2032) & (K Units) Table 58. Global Targeted Therapy Drugs for Melanoma Sales Market Share in Volume by Application (2027-2032) Table 59. Global Targeted Therapy Drugs for Melanoma Sales by Application (2027-2032) & (US$ Million) Table 60. Global Targeted Therapy Drugs for Melanoma Sales Market Share in Value by Application (2027-2032) Table 61. Global Targeted Therapy Drugs for Melanoma Price by Application (2027-2032) & (US$/Unit) Table 62. North America Targeted Therapy Drugs for Melanoma Sales by Application (2021-2026) & (K Units) Table 63. North America Targeted Therapy Drugs for Melanoma Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Targeted Therapy Drugs for Melanoma Sales by Application (2021-2026) & (K Units) Table 65. Europe Targeted Therapy Drugs for Melanoma Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Targeted Therapy Drugs for Melanoma Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Targeted Therapy Drugs for Melanoma Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Targeted Therapy Drugs for Melanoma Sales by Application (2021-2026) & (K Units) Table 69. Latin America Targeted Therapy Drugs for Melanoma Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Targeted Therapy Drugs for Melanoma Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Targeted Therapy Drugs for Melanoma Sales by Application (2021-2026) & (US$ Million) Table 72. Novartis Company Information Table 73. Novartis Business Overview Table 74. Novartis Targeted Therapy Drugs for Melanoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Novartis Targeted Therapy Drugs for Melanoma Product Portfolio Table 76. Novartis Recent Development Table 77. Pfizer Company Information Table 78. Pfizer Business Overview Table 79. Pfizer Targeted Therapy Drugs for Melanoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Pfizer Targeted Therapy Drugs for Melanoma Product Portfolio Table 81. Pfizer Recent Development Table 82. KeChow Pharmaceuticals Company Information Table 83. KeChow Pharmaceuticals Business Overview Table 84. KeChow Pharmaceuticals Targeted Therapy Drugs for Melanoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. KeChow Pharmaceuticals Targeted Therapy Drugs for Melanoma Product Portfolio Table 86. KeChow Pharmaceuticals Recent Development Table 87. Roche Company Information Table 88. Roche Business Overview Table 89. Roche Targeted Therapy Drugs for Melanoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Roche Targeted Therapy Drugs for Melanoma Product Portfolio Table 91. Roche Recent Development Table 92. North America Targeted Therapy Drugs for Melanoma Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 93. North America Targeted Therapy Drugs for Melanoma Sales by Country (2021-2026) & (K Units) Table 94. North America Targeted Therapy Drugs for Melanoma Sales Market Share by Country (2021-2026) Table 95. North America Targeted Therapy Drugs for Melanoma Sales Forecast by Country (2027-2032) & (K Units) Table 96. North America Targeted Therapy Drugs for Melanoma Sales Market Share Forecast by Country (2027-2032) Table 97. North America Targeted Therapy Drugs for Melanoma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 98. North America Targeted Therapy Drugs for Melanoma Market Size by Country (2021-2026) & (US$ Million) Table 99. North America Targeted Therapy Drugs for Melanoma Market Share by Country (2021-2026) Table 100. North America Targeted Therapy Drugs for Melanoma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 101. North America Targeted Therapy Drugs for Melanoma Market Share Forecast by Country (2027-2032) Table 102. Europe Targeted Therapy Drugs for Melanoma Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 103. Europe Targeted Therapy Drugs for Melanoma Sales by Country (2021-2026) & (K Units) Table 104. Europe Targeted Therapy Drugs for Melanoma Sales Market Share by Country (2021-2026) Table 105. Europe Targeted Therapy Drugs for Melanoma Sales Forecast by Country (2027-2032) & (K Units) Table 106. Europe Targeted Therapy Drugs for Melanoma Sales Market Share Forecast by Country (2027-2032) Table 107. Europe Targeted Therapy Drugs for Melanoma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. Europe Targeted Therapy Drugs for Melanoma Market Size by Country (2021-2026) & (US$ Million) Table 109. Europe Targeted Therapy Drugs for Melanoma Market Share by Country (2021-2026) Table 110. Europe Targeted Therapy Drugs for Melanoma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. Europe Targeted Therapy Drugs for Melanoma Market Share Forecast by Country (2027-2032) Table 112. Asia-Pacific Targeted Therapy Drugs for Melanoma Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. Asia-Pacific Targeted Therapy Drugs for Melanoma Sales by Country (2021-2026) & (K Units) Table 114. Asia-Pacific Targeted Therapy Drugs for Melanoma Sales Market Share by Country (2021-2026) Table 115. Asia-Pacific Targeted Therapy Drugs for Melanoma Sales Forecast by Country (2027-2032) & (K Units) Table 116. Asia-Pacific Targeted Therapy Drugs for Melanoma Sales Market Share Forecast by Country (2027-2032) Table 117. Asia-Pacific Targeted Therapy Drugs for Melanoma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Asia-Pacific Targeted Therapy Drugs for Melanoma Market Size by Country (2021-2026) & (US$ Million) Table 119. Asia-Pacific Targeted Therapy Drugs for Melanoma Market Share by Country (2021-2026) Table 120. Asia-Pacific Targeted Therapy Drugs for Melanoma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Asia-Pacific Targeted Therapy Drugs for Melanoma Market Share Forecast by Country (2027-2032) Table 122. Latin America Targeted Therapy Drugs for Melanoma Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Latin America Targeted Therapy Drugs for Melanoma Sales by Country (2021-2026) & (K Units) Table 124. Latin America Targeted Therapy Drugs for Melanoma Sales Market Share by Country (2021-2026) Table 125. Latin America Targeted Therapy Drugs for Melanoma Sales Forecast by Country (2027-2032) & (K Units) Table 126. Latin America Targeted Therapy Drugs for Melanoma Sales Market Share Forecast by Country (2027-2032) Table 127. Latin America Targeted Therapy Drugs for Melanoma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Latin America Targeted Therapy Drugs for Melanoma Market Size by Country (2021-2026) & (US$ Million) Table 129. Latin America Targeted Therapy Drugs for Melanoma Market Share by Country (2021-2026) Table 130. Latin America Targeted Therapy Drugs for Melanoma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Latin America Targeted Therapy Drugs for Melanoma Market Share Forecast by Country (2027-2032) Table 132. Middle East and Africa Targeted Therapy Drugs for Melanoma Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Middle East and Africa Targeted Therapy Drugs for Melanoma Sales by Country (2021-2026) & (K Units) Table 134. Middle East and Africa Targeted Therapy Drugs for Melanoma Sales Market Share by Country (2021-2026) Table 135. Middle East and Africa Targeted Therapy Drugs for Melanoma Sales Forecast by Country (2027-2032) & (K Units) Table 136. Middle East and Africa Targeted Therapy Drugs for Melanoma Sales Market Share Forecast by Country (2027-2032) Table 137. Middle East and Africa Targeted Therapy Drugs for Melanoma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Middle East and Africa Targeted Therapy Drugs for Melanoma Market Size by Country (2021-2026) & (US$ Million) Table 139. Middle East and Africa Targeted Therapy Drugs for Melanoma Market Share by Country (2021-2026) Table 140. Middle East and Africa Targeted Therapy Drugs for Melanoma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Middle East and Africa Targeted Therapy Drugs for Melanoma Market Share Forecast by Country (2027-2032) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Targeted Therapy Drugs for Melanoma Distributors List Table 145. Targeted Therapy Drugs for Melanoma Customers List Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Targeted Therapy Drugs for Melanoma Image Figure 2. Global Targeted Therapy Drugs for Melanoma Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Targeted Therapy Drugs for Melanoma Market Size (2021-2032) & (US$ Million) Figure 4. Global Targeted Therapy Drugs for Melanoma Sales (2021-2032) & (K Units) Figure 5. MEK Inhibitors Image Figure 6. Global MEK Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 7. BRAF Inhibitors Image Figure 8. Global BRAF Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Targeted Therapy Drugs for Melanoma Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Targeted Therapy Drugs for Melanoma Market Share by Type 2025 VS 2032 Figure 13. North America Targeted Therapy Drugs for Melanoma Sales Market Share in Volume by Type in 2025 Figure 14. North America Targeted Therapy Drugs for Melanoma Sales Market Share in Value by Type in 2025 Figure 15. Europe Targeted Therapy Drugs for Melanoma Sales Market Share in Volume by Type in 2025 Figure 16. Europe Targeted Therapy Drugs for Melanoma Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Targeted Therapy Drugs for Melanoma Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Targeted Therapy Drugs for Melanoma Sales Market Share in Value by Type in 2025 Figure 19. Latin America Targeted Therapy Drugs for Melanoma Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Targeted Therapy Drugs for Melanoma Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Targeted Therapy Drugs for Melanoma Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Targeted Therapy Drugs for Melanoma Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Targeted Therapy Drugs for Melanoma Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital and Clinic Image Figure 26. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Pharmacy Image Figure 28. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Targeted Therapy Drugs for Melanoma Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Targeted Therapy Drugs for Melanoma Market Share by Application 2025 VS 2032 Figure 33. North America Targeted Therapy Drugs for Melanoma Sales Market Share in Volume by Application in 2025 Figure 34. North America Targeted Therapy Drugs for Melanoma Sales Market Share in Value by Application in 2025 Figure 35. Europe Targeted Therapy Drugs for Melanoma Sales Market Share in Volume by Application in 2025 Figure 36. Europe Targeted Therapy Drugs for Melanoma Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Targeted Therapy Drugs for Melanoma Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Targeted Therapy Drugs for Melanoma Sales Market Share in Value by Application in 2025 Figure 39. Latin America Targeted Therapy Drugs for Melanoma Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Targeted Therapy Drugs for Melanoma Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Targeted Therapy Drugs for Melanoma Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Targeted Therapy Drugs for Melanoma Sales Market Share in Value by Application in 2025 Figure 43. North America Targeted Therapy Drugs for Melanoma Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Targeted Therapy Drugs for Melanoma Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Targeted Therapy Drugs for Melanoma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Targeted Therapy Drugs for Melanoma Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Targeted Therapy Drugs for Melanoma Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Targeted Therapy Drugs for Melanoma Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Targeted Therapy Drugs for Melanoma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Targeted Therapy Drugs for Melanoma Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Targeted Therapy Drugs for Melanoma Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Targeted Therapy Drugs for Melanoma Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Targeted Therapy Drugs for Melanoma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Targeted Therapy Drugs for Melanoma Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Targeted Therapy Drugs for Melanoma Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Targeted Therapy Drugs for Melanoma Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Targeted Therapy Drugs for Melanoma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Targeted Therapy Drugs for Melanoma Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Targeted Therapy Drugs for Melanoma Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Targeted Therapy Drugs for Melanoma Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Targeted Therapy Drugs for Melanoma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Targeted Therapy Drugs for Melanoma Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Targeted Therapy Drugs for Melanoma Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Targeted Therapy Drugs for Melanoma Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • MEK Inhibitors
  • BRAF Inhibitors
  • Other
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Novartis
  • Pfizer
  • KeChow Pharmaceuticals
  • Roche

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Targeted Therapy Drugs for Melanoma Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Targeted Therapy Drugs for Melanoma Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Targeted Therapy Drugs for Melanoma Market by Type
  6. 1.3.1 MEK Inhibitors
  7. 1.3.2 BRAF Inhibitors
  8. 1.3.3 Other
  9. 1.4 Global Targeted Therapy Drugs for Melanoma Market Size by Type
  10. 1.4.1 Global Targeted Therapy Drugs for Melanoma Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Targeted Therapy Drugs for Melanoma Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Targeted Therapy Drugs for Melanoma Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Targeted Therapy Drugs for Melanoma Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Targeted Therapy Drugs for Melanoma Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Targeted Therapy Drugs for Melanoma Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Targeted Therapy Drugs for Melanoma Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Targeted Therapy Drugs for Melanoma Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Targeted Therapy Drugs for Melanoma Industry Trends
  2. 2.2 Targeted Therapy Drugs for Melanoma Industry Drivers
  3. 2.3 Targeted Therapy Drugs for Melanoma Industry Opportunities and Challenges
  4. 2.4 Targeted Therapy Drugs for Melanoma Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Targeted Therapy Drugs for Melanoma Revenue (2021-2026)
  2. 3.2 Global Top Players by Targeted Therapy Drugs for Melanoma Sales (2021-2026)
  3. 3.3 Global Top Players by Targeted Therapy Drugs for Melanoma Price (2021-2026)
  4. 3.4 Global Targeted Therapy Drugs for Melanoma Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Targeted Therapy Drugs for Melanoma Major Company Production Sites & Headquarters
  6. 3.6 Global Targeted Therapy Drugs for Melanoma Company, Product Type & Application
  7. 3.7 Global Targeted Therapy Drugs for Melanoma Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Targeted Therapy Drugs for Melanoma Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Targeted Therapy Drugs for Melanoma Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Targeted Therapy Drugs for Melanoma Tier 1, Tier 2, and Tier 3
4 Targeted Therapy Drugs for Melanoma Regional Status and Outlook
  1. 4.1 Global Targeted Therapy Drugs for Melanoma Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Targeted Therapy Drugs for Melanoma Historic Market Size by Region
  3. 4.2.1 Global Targeted Therapy Drugs for Melanoma Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Targeted Therapy Drugs for Melanoma Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Targeted Therapy Drugs for Melanoma Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Targeted Therapy Drugs for Melanoma Forecasted Market Size by Region
  7. 4.3.1 Global Targeted Therapy Drugs for Melanoma Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Targeted Therapy Drugs for Melanoma Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Targeted Therapy Drugs for Melanoma Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Targeted Therapy Drugs for Melanoma by Application
  1. 5.1 Targeted Therapy Drugs for Melanoma Market by Application
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Targeted Therapy Drugs for Melanoma Market Size by Application
  6. 5.2.1 Global Targeted Therapy Drugs for Melanoma Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Targeted Therapy Drugs for Melanoma Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Targeted Therapy Drugs for Melanoma Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Targeted Therapy Drugs for Melanoma Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Targeted Therapy Drugs for Melanoma Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Targeted Therapy Drugs for Melanoma Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Targeted Therapy Drugs for Melanoma Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Targeted Therapy Drugs for Melanoma Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Targeted Therapy Drugs for Melanoma Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Targeted Therapy Drugs for Melanoma Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Targeted Therapy Drugs for Melanoma Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Targeted Therapy Drugs for Melanoma Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 KeChow Pharmaceuticals
  14. 6.3.1 KeChow Pharmaceuticals Company Information
  15. 6.3.2 KeChow Pharmaceuticals Business Overview
  16. 6.3.3 KeChow Pharmaceuticals Targeted Therapy Drugs for Melanoma Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 KeChow Pharmaceuticals Targeted Therapy Drugs for Melanoma Product Portfolio
  18. 6.3.5 KeChow Pharmaceuticals Recent Developments
  19. 6.4 Roche
  20. 6.4.1 Roche Company Information
  21. 6.4.2 Roche Business Overview
  22. 6.4.3 Roche Targeted Therapy Drugs for Melanoma Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Roche Targeted Therapy Drugs for Melanoma Product Portfolio
  24. 6.4.5 Roche Recent Developments
7 North America by Country
  1. 7.1 North America Targeted Therapy Drugs for Melanoma Sales by Country
  2. 7.1.1 North America Targeted Therapy Drugs for Melanoma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Targeted Therapy Drugs for Melanoma Sales by Country (2021-2026)
  4. 7.1.3 North America Targeted Therapy Drugs for Melanoma Sales Forecast by Country (2027-2032)
  5. 7.2 North America Targeted Therapy Drugs for Melanoma Market Size by Country
  6. 7.2.1 North America Targeted Therapy Drugs for Melanoma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Targeted Therapy Drugs for Melanoma Market Size by Country (2021-2026)
  8. 7.2.3 North America Targeted Therapy Drugs for Melanoma Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Targeted Therapy Drugs for Melanoma Sales by Country
  2. 8.1.1 Europe Targeted Therapy Drugs for Melanoma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Targeted Therapy Drugs for Melanoma Sales by Country (2021-2026)
  4. 8.1.3 Europe Targeted Therapy Drugs for Melanoma Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Targeted Therapy Drugs for Melanoma Market Size by Country
  6. 8.2.1 Europe Targeted Therapy Drugs for Melanoma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Targeted Therapy Drugs for Melanoma Market Size by Country (2021-2026)
  8. 8.2.3 Europe Targeted Therapy Drugs for Melanoma Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Targeted Therapy Drugs for Melanoma Sales by Country
  2. 9.1.1 Asia-Pacific Targeted Therapy Drugs for Melanoma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Targeted Therapy Drugs for Melanoma Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Targeted Therapy Drugs for Melanoma Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Targeted Therapy Drugs for Melanoma Market Size by Country
  6. 9.2.1 Asia-Pacific Targeted Therapy Drugs for Melanoma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Targeted Therapy Drugs for Melanoma Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Targeted Therapy Drugs for Melanoma Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Targeted Therapy Drugs for Melanoma Sales by Country
  2. 10.1.1 South America Targeted Therapy Drugs for Melanoma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Targeted Therapy Drugs for Melanoma Sales by Country (2021-2026)
  4. 10.1.3 South America Targeted Therapy Drugs for Melanoma Sales Forecast by Country (2027-2032)
  5. 10.2 South America Targeted Therapy Drugs for Melanoma Market Size by Country
  6. 10.2.1 South America Targeted Therapy Drugs for Melanoma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Targeted Therapy Drugs for Melanoma Market Size by Country (2021-2026)
  8. 10.2.3 South America Targeted Therapy Drugs for Melanoma Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Targeted Therapy Drugs for Melanoma Sales by Country
  2. 11.1.1 Middle East and Africa Targeted Therapy Drugs for Melanoma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Targeted Therapy Drugs for Melanoma Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Targeted Therapy Drugs for Melanoma Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Targeted Therapy Drugs for Melanoma Market Size by Country
  6. 11.2.1 Middle East and Africa Targeted Therapy Drugs for Melanoma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Targeted Therapy Drugs for Melanoma Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Targeted Therapy Drugs for Melanoma Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Targeted Therapy Drugs for Melanoma Value Chain Analysis
  2. 12.1.1 Targeted Therapy Drugs for Melanoma Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Targeted Therapy Drugs for Melanoma Production Mode & Process
  7. 12.2 Targeted Therapy Drugs for Melanoma Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Targeted Therapy Drugs for Melanoma Distributors
  10. 12.2.3 Targeted Therapy Drugs for Melanoma Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst